Basic Information
RNALocate ID: RLID:11001980
RNA Symbol: hsa-miR-193a-3p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-193a-3p
RNA ID: miRBase:MIMAT0000459
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23539611
Tissue/Cell Line: Seminal plasma
Method: Microarray
Description: In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001854 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001855 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11001973 Exosome Urine 28246603
RLID:11001974 Exosome B cell line (Raji)|Primary dendritic cells|T cell line (J77) 21505438
RLID:11001975 Exosome Brain tissue 23382797
RLID:11001976 Exosome Plasma 23663360
RLID:11001977 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001978 Exosome Serum 24683445
RLID:11001979 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11001981 Microvesicle Hepatoma cells 23771658
RLID:11001982 Microvesicle Colon cancer cell line (LIM1863) 25330373
RLID-D:11000102 Exosome Breast milk
RLID-D:11000387 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-193a-3p Multiple sclerosis chronic progressive MNDR-E-MI-22928
MNDR hsa-miR-193a-3p Oral squamous cell carcinoma MNDR-E-MI-22929
MNDR hsa-miR-193a-3p Medulloblastoma MNDR-E-MI-22930
MNDR hsa-miR-193a-3p Small intestinal neuroendocrine tumor MNDR-E-MI-22931
MNDR hsa-miR-193a-3p Ovarian clear cell carcinoma MNDR-E-MI-22932
MNDR hsa-miR-193a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-22933
MNDR hsa-miR-193a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-22934
MNDR hsa-miR-193a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-22935
MNDR hsa-miR-193a-3p Her2-receptor positive breast cancer MNDR-E-MI-22936
MNDR hsa-miR-193a-3p Breast cancer luminal a MNDR-E-MI-22937
MNDR hsa-miR-193a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-22938
MNDR hsa-miR-193a-3p B cell acute lymphoblastic leukemia MNDR-E-MI-22939
MNDR hsa-miR-193a-3p Neurofibromatosis 1 MNDR-E-MI-22940
MNDR hsa-miR-193a-3p Small intestine cancer MNDR-E-MI-22941
MNDR hsa-miR-193a-3p Prostate cancer MNDR-E-MI-22942
MNDR hsa-miR-193a-3p Gastric cancer MNDR-E-MI-22943
MNDR hsa-miR-193a-3p Alzheimer disease MNDR-E-MI-22944
MNDR hsa-miR-193a-3p Dysautonomia familial MNDR-E-MI-22945
MNDR hsa-miR-193a-3p Polycystic ovary syndrome MNDR-E-MI-22946
MNDR hsa-miR-193a-3p Myotonic dystrophy MNDR-E-MI-22947
MNDR hsa-miR-193a-3p Cardiovascular disease MNDR-E-MI-22948
MNDR hsa-miR-193a-3p Lung cancer MNDR-E-MI-22949
MNDR hsa-miR-193a-3p Parkinson disease MNDR-E-MI-22950
MNDR hsa-miR-193a-3p Basal-like breast cancer MNDR-E-MI-22951
MNDR hsa-miR-193a-3p Thyroid cancer MNDR-E-MI-22952
MNDR hsa-miR-193a-3p Pituitary neoplasms MNDR-E-MI-22953
MNDR hsa-miR-193a-3p Pancreatic cancer MNDR-E-MI-22954
MNDR hsa-miR-193a-3p Nephroblastoma MNDR-E-MI-22955
MNDR hsa-miR-193a-3p Colon cancer MNDR-E-MI-22956
MNDR hsa-miR-193a-3p Ischemic attack transient MNDR-E-MI-22957
MNDR hsa-miR-193a-3p Colon adenocarcinoma MNDR-E-MI-22958
MNDR hsa-miR-193a-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-22959
MNDR hsa-miR-193a-3p Familial ovarian cancer MNDR-E-MI-22960
MNDR hsa-miR-193a-3p Acromegaly MNDR-E-MI-22961
MNDR hsa-miR-193a-3p Prostate adenocarcinoma MNDR-E-MI-22962
MNDR hsa-miR-193a-3p Carcinoma ductal breast MNDR-E-MI-22963
MNDR hsa-miR-193a-3p Invasive ductal carcinoma MNDR-E-MI-22964
MNDR hsa-miR-193a-3p Glioblastoma MNDR-E-MI-22965
MNDR hsa-miR-193a-3p Astrocytoma MNDR-E-MI-22966
MNDR hsa-miR-193a-3p Glioma MNDR-E-MI-22967
MNDR hsa-miR-193a-3p Amyotrophic lateral sclerosis MNDR-E-MI-22968
MNDR hsa-miR-193a-3p Temporal lobe epilepsy MNDR-E-MI-22969
MNDR hsa-miR-193a-3p Uterine cancer MNDR-E-MI-22970
MNDR hsa-miR-193a-3p Cervical adenocarcinoma MNDR-E-MI-22971
MNDR hsa-miR-193a-3p Gastric adenocarcinoma MNDR-E-MI-22972
MNDR hsa-miR-193a-3p Cervical squamous cell carcinoma MNDR-E-MI-22973
MNDR hsa-miR-193a-3p Pituitary adenoma MNDR-E-MI-22974
MNDR hsa-miR-193a-3p Lung squamous cell carcinoma MNDR-E-MI-22975
MNDR hsa-miR-193a-3p Carcinoma lung non-small-cell MNDR-E-MI-22976
MNDR hsa-miR-193a-3p Thyroid carcinoma MNDR-E-MI-22977
MNDR hsa-miR-193a-3p Papillary thyroid carcinoma MNDR-E-MI-22978
MNDR hsa-miR-193a-3p Bladder urothelial carcinoma MNDR-E-MI-22979
MNDR hsa-miR-193a-3p Pancreatic adenocarcinoma MNDR-E-MI-22980
MNDR hsa-miR-193a-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-22981
MNDR hsa-miR-193a-3p Carcinoma renal cell MNDR-E-MI-22982
MNDR hsa-miR-193a-3p Kidney renal papillary cell carcinoma MNDR-E-MI-22983
MNDR hsa-miR-193a-3p Clear cell renal cell carcinoma MNDR-E-MI-22984
MNDR hsa-miR-193a-3p Cholangiocarcinoma MNDR-E-MI-22985
MNDR hsa-miR-193a-3p Esophageal cancer MNDR-E-MI-22986
MNDR hsa-miR-193a-3p Lung small cell carcinoma MNDR-E-MI-22987
MNDR hsa-miR-193a-3p Synovial sarcoma MNDR-E-MI-22988
MNDR hsa-miR-193a-3p T acute lymphoblastic leukemia MNDR-E-MI-22989
MNDR hsa-miR-193a-3p Acute t cell leukemia MNDR-E-MI-22990
MNDR hsa-miR-193a-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-22991
MNDR hsa-miR-193a-3p Breast invasive carcinoma MNDR-E-MI-22992
MNDR hsa-miR-193a-3p Hepatocellular carcinoma MNDR-E-MI-22993
MNDR hsa-miR-193a-3p Familiar ovarian carcinoma MNDR-E-MI-22994
MNDR hsa-miR-193a-3p Barrett's adenocarcinoma MNDR-E-MI-22995
MNDR hsa-miR-193a-3p Hodgkin lymphoma MNDR-E-MI-22996
MNDR hsa-miR-193a-3p Ulcerative colitis MNDR-E-MI-22997
MNDR hsa-miR-193a-3p Burkitt lymphoma MNDR-E-MI-22998
MNDR hsa-miR-193a-3p Tonsil cancer MNDR-E-MI-22999
MNDR hsa-miR-193a-3p Degenerative disc disease MNDR-E-MI-23000
MNDR hsa-miR-193a-3p Acute myelocytic leukemia MNDR-E-MI-23001
MNDR hsa-miR-193a-3p Colorectal cancer MNDR-E-MI-23002
MNDR hsa-miR-193a-3p Nasopharynx carcinoma MNDR-E-MI-23003
MNDR hsa-miR-193a-3p Acute lymphocytic leukemia MNDR-E-MI-23004
MNDR hsa-miR-193a-3p Esophageal squamous cell carcinoma MNDR-E-MI-23005
MNDR hsa-miR-193a-3p Ependymoma MNDR-E-MI-23006
MNDR hsa-miR-193a-3p Inflammation MNDR-E-MI-23007
MNDR hsa-miR-193a-3p Nasopharyngeal cancer MNDR-E-MI-23008
MNDR hsa-miR-193a-3p Pseudorabies MNDR-E-MI-23009
MNDR hsa-miR-193a-3p Barrett's carcinogenesis MNDR-E-MI-23010
MNDR hsa-miR-193a-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-23011
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CASC2 Homo sapiens RR00277759
TOP